printTracy Krughoff of BIO talks to Barry Greene [2], president and COO of Alnylam Pharmaceuticals [3] (ALNY) at the Seventh Annual BIO Investor Forum in San Francisco. Alnylam has developed a deep pipeline of drug products to treat a multitude of diseases through RNAi therapeutics. Listen to the podcast [4]